Risk Stratification for Antiemetics May Prevent OvertreatmentNovember 16th 2015
Identifying breast cancer patients who are at low risk for chemotherapy-induced nausea and vomiting before the start of treatment may help avoid unnecessary use of antiemetic medications without compromising quality of care.
Experts Offer Guidance on Integrating Palliative Services Into Cancer CareOctober 12th 2015
Palliative care should be provided with cancer care early in the course of illness for all patients with advanced disease, according to a new guidance statement from ASCO and the American Academy of Hospice and Palliative Medicine.
Overcoming Drug Resistance in Lung CancerApril 27th 2015
Patients with lung cancer are increasingly receiving targeted therapies that induce complete disease remissions, but they can also develop resistance to these drugs. New efforts are now underway to discover and develop new options for patients experiencing drug resistance.
Aromatase Inhibitor Side Effects No Surrogate for Efficacy in Breast CancerDecember 16th 2014
A large trial showed that treatment-emergent vasomotor and/or joint symptoms do not correlate with any improvement in recurrence-free survival in postmenopausal breast cancer patients treated with aromatase inhibitors.